Latest news with #NorthEastRubber
Yahoo
27-05-2025
- Business
- Yahoo
Asian Penny Stocks To Watch In May 2025
As global markets face volatility, with significant movements in U.S. Treasury yields and tariff threats impacting indices worldwide, investors are keeping a close eye on opportunities that might emerge amidst the uncertainty. Penny stocks, often considered relics of past market eras, still hold potential for those seeking affordable entry points into smaller or newer companies with growth prospects. Despite their historical reputation for speculation, these stocks can offer value when backed by strong financials and may present unique opportunities for investors looking to uncover under-the-radar companies poised for long-term success. Name Share Price Market Cap Financial Health Rating North East Rubber (SET:NER) THB4.16 THB7.69B ★★★★☆☆ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ YKGI (Catalist:YK9) SGD0.096 SGD40.8M ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.18 SGD35.86M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.04 SGD8.03B ★★★★★☆ Ever Sunshine Services Group (SEHK:1995) HK$1.84 HK$3.18B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.43 HK$50.72B ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$719.28M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.12 HK$1.77B ★★★★★★ Click here to see the full list of 1,169 stocks from our Asian Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Nickel Asia Corporation is involved in the mining and exploration of nickel saprolite, limonite ore, limestone, and quarry materials in the Philippines with a market cap of ₱34.69 billion. Operations: Nickel Asia's revenue is primarily derived from its mining operations, with significant contributions from Mining - TMC (₱8.59 billion) and Mining - RTN (₱5.44 billion), supplemented by services related to RTN/TMC/CDTN (₱1.18 billion) and power generation through EPI (₱1.18 billion) and NAC (₱208.07 million). Market Cap: ₱34.69B Nickel Asia Corporation, with a market cap of ₱34.69 billion, recently reported strong first-quarter earnings growth, with revenue increasing to ₱2.93 billion and net income rising to ₱501.03 million from the previous year. Despite this improvement, the company faces challenges such as declining profit margins and negative earnings growth over the past year. However, its financial position remains robust, with short-term assets exceeding liabilities and cash covering total debt. A strategic alliance with DMCI Mining aims to enhance nickel processing capabilities in the Philippines, potentially boosting long-term prospects despite current volatility in returns and low return on equity (7.4%). Click here and access our complete financial health analysis report to understand the dynamics of Nickel Asia. Assess Nickel Asia's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: 3D Medicines Inc. is a biopharmaceutical company focused on researching, developing, and commercializing oncology products and other drug candidates for cancer treatment in China, with a market cap of approximately HK$974.98 million. Operations: The company's revenue is primarily derived from its Biopharmaceutical Research and Development segment, which generated CN¥445.65 million. Market Cap: HK$974.98M 3D Medicines Inc., with a market cap of HK$974.98 million, is focused on oncology products in China. Despite being unprofitable, it has reduced its net loss significantly to CN¥182.66 million for 2024 from the prior year and reported revenues of CN¥445.65 million from its biopharmaceutical R&D segment. The company maintains a strong financial position with short-term assets surpassing liabilities and more cash than debt, ensuring a cash runway exceeding three years at current free cash flow levels. Recent strategic advancements include patent filings for lipid nanoparticles, enhancing their competitive edge in mRNA cancer vaccine development through AI-driven innovation. Unlock comprehensive insights into our analysis of 3D Medicines stock in this financial health report. Gain insights into 3D Medicines' historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: CASIN Real Estate Development Group Co., Ltd. (SZSE:000838) is involved in real estate development and management, with a market cap of CN¥2.85 billion. Operations: The company generates its revenue of CN¥559.65 million from operations within China. Market Cap: CN¥2.85B CASIN Real Estate Development Group Ltd. has faced financial challenges, with revenue dropping to CN¥826.46 million in 2024 from CN¥4.02 billion the previous year, and a net loss increasing to CN¥260.16 million. Despite these setbacks, the company has improved its debt position significantly over five years, reducing its debt-to-equity ratio from 186.3% to 62.6%. Short-term assets of CN¥2.2 billion exceed both short-term and long-term liabilities, providing some financial stability despite ongoing losses and a high net debt-to-equity ratio of 42.7%. The management team is experienced, with an average tenure of over four years. Get an in-depth perspective on CASIN Real Estate Development GroupLtd's performance by reading our balance sheet health report here. Gain insights into CASIN Real Estate Development GroupLtd's past trends and performance with our report on the company's historical track record. Navigate through the entire inventory of 1,169 Asian Penny Stocks here. Seeking Other Investments? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include PSE:NIKL SEHK:1244 and SZSE:000838. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
27-05-2025
- Business
- Yahoo
Asian Market Highlights: Top Penny Stocks For May 2025
As global markets grapple with volatility and geopolitical uncertainties, investors are increasingly looking toward Asia for potential opportunities. Penny stocks, though often seen as relics of past market eras, remain relevant due to their affordability and growth potential when backed by strong financials. In this article, we explore several Asian penny stocks that stand out for their robust fundamentals and the promise they hold in today's complex economic landscape. Name Share Price Market Cap Financial Health Rating North East Rubber (SET:NER) THB4.16 THB7.69B ★★★★☆☆ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ YKGI (Catalist:YK9) SGD0.096 SGD40.8M ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.18 SGD35.86M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.04 SGD8.03B ★★★★★☆ Ever Sunshine Services Group (SEHK:1995) HK$1.84 HK$3.18B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.43 HK$50.72B ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$719.28M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.12 HK$1.77B ★★★★★★ Click here to see the full list of 1,169 stocks from our Asian Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Global New Material International Holdings Limited is an investment holding company that produces and sells pearlescent pigment, functional mica filler, and related products both in China and internationally, with a market cap of HK$4.91 billion. Operations: The company generates revenue from its operations in the PRC, amounting to CN¥1.33 billion, and from its business activities in Korea, which contribute CN¥316.59 million. Market Cap: HK$4.91B Global New Material International Holdings has demonstrated significant earnings growth, reporting CN¥1.65 billion in sales for 2024, up from CN¥1.06 billion the previous year. The company has a solid financial position with short-term assets of CN¥4.3 billion exceeding both its short and long-term liabilities, suggesting sound liquidity management. Despite a low Return on Equity of 7.4%, earnings growth outpaced the industry average at 33.4% last year, indicating strong operational performance. However, increased debt levels and lower profit margins compared to last year may pose challenges moving forward despite well-covered interest payments and no recent shareholder dilution. Navigate through the intricacies of Global New Material International Holdings with our comprehensive balance sheet health report here. Gain insights into Global New Material International Holdings' future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Thakral Corporation Ltd is an investment holding company that markets and distributes beauty, fragrance, and lifestyle products across Australia, India, Japan, the People's Republic of China, and Singapore with a market cap of SGD152.47 million. Operations: Thakral's revenue is primarily derived from its Lifestyle segment, which generated SGD273.03 million, while its Investment segment contributed SGD15.78 million. Market Cap: SGD152.47M Thakral Corporation Ltd has shown robust financial performance, with sales reaching S$288.81 million for 2024, driven primarily by its Lifestyle segment. The company reported a net income of S$28.81 million, reflecting substantial earnings growth over the previous year. Its board and management team have undergone changes to enhance governance and sustainability efforts, including the formation of a Sustainability Committee. Despite its low Return on Equity at 16.2%, Thakral maintains satisfactory debt levels with interest payments well-covered by EBIT (4.1x coverage). Recent dividend affirmations underscore its commitment to shareholder returns amidst volatile share prices. Take a closer look at Thakral's potential here in our financial health report. Review our historical performance report to gain insights into Thakral's track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Q & M Dental Group (Singapore) Limited is an investment holding company that offers private dental healthcare services in Singapore, Malaysia, China, and internationally with a market cap of SGD336.71 million. Operations: The company generates revenue primarily from its Core Dental Business, which accounts for SGD173.79 million, alongside Other Businesses contributing SGD6.89 million. Market Cap: SGD336.71M Q & M Dental Group (Singapore) Limited, with a market cap of SGD336.71 million, is trading at a significant discount to its estimated fair value. Despite experiencing a large one-off loss of SGD5.2 million in 2024, the company has demonstrated strong earnings growth of 27.1% over the past year, outpacing the healthcare industry average. The management team is experienced with satisfactory debt levels and well-covered interest payments by EBIT (4.4x coverage). Recent share buyback authorization reflects strategic capital management while maintaining stable weekly volatility and improved profit margins year-on-year from 6.3% to 8.1%. Unlock comprehensive insights into our analysis of Q & M Dental Group (Singapore) stock in this financial health report. Review our growth performance report to gain insights into Q & M Dental Group (Singapore)'s future. Embark on your investment journey to our 1,169 Asian Penny Stocks selection here. Seeking Other Investments? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:6616 SGX:AWI and SGX:QC7. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26-05-2025
- Business
- Yahoo
Asian Market Highlights: Top Penny Stocks For May 2025
As global markets grapple with volatility and geopolitical uncertainties, investors are increasingly looking toward Asia for potential opportunities. Penny stocks, though often seen as relics of past market eras, remain relevant due to their affordability and growth potential when backed by strong financials. In this article, we explore several Asian penny stocks that stand out for their robust fundamentals and the promise they hold in today's complex economic landscape. Name Share Price Market Cap Financial Health Rating North East Rubber (SET:NER) THB4.16 THB7.69B ★★★★☆☆ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ YKGI (Catalist:YK9) SGD0.096 SGD40.8M ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.18 SGD35.86M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.04 SGD8.03B ★★★★★☆ Ever Sunshine Services Group (SEHK:1995) HK$1.84 HK$3.18B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.43 HK$50.72B ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$719.28M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.12 HK$1.77B ★★★★★★ Click here to see the full list of 1,169 stocks from our Asian Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Global New Material International Holdings Limited is an investment holding company that produces and sells pearlescent pigment, functional mica filler, and related products both in China and internationally, with a market cap of HK$4.91 billion. Operations: The company generates revenue from its operations in the PRC, amounting to CN¥1.33 billion, and from its business activities in Korea, which contribute CN¥316.59 million. Market Cap: HK$4.91B Global New Material International Holdings has demonstrated significant earnings growth, reporting CN¥1.65 billion in sales for 2024, up from CN¥1.06 billion the previous year. The company has a solid financial position with short-term assets of CN¥4.3 billion exceeding both its short and long-term liabilities, suggesting sound liquidity management. Despite a low Return on Equity of 7.4%, earnings growth outpaced the industry average at 33.4% last year, indicating strong operational performance. However, increased debt levels and lower profit margins compared to last year may pose challenges moving forward despite well-covered interest payments and no recent shareholder dilution. Navigate through the intricacies of Global New Material International Holdings with our comprehensive balance sheet health report here. Gain insights into Global New Material International Holdings' future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Thakral Corporation Ltd is an investment holding company that markets and distributes beauty, fragrance, and lifestyle products across Australia, India, Japan, the People's Republic of China, and Singapore with a market cap of SGD152.47 million. Operations: Thakral's revenue is primarily derived from its Lifestyle segment, which generated SGD273.03 million, while its Investment segment contributed SGD15.78 million. Market Cap: SGD152.47M Thakral Corporation Ltd has shown robust financial performance, with sales reaching S$288.81 million for 2024, driven primarily by its Lifestyle segment. The company reported a net income of S$28.81 million, reflecting substantial earnings growth over the previous year. Its board and management team have undergone changes to enhance governance and sustainability efforts, including the formation of a Sustainability Committee. Despite its low Return on Equity at 16.2%, Thakral maintains satisfactory debt levels with interest payments well-covered by EBIT (4.1x coverage). Recent dividend affirmations underscore its commitment to shareholder returns amidst volatile share prices. Take a closer look at Thakral's potential here in our financial health report. Review our historical performance report to gain insights into Thakral's track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Q & M Dental Group (Singapore) Limited is an investment holding company that offers private dental healthcare services in Singapore, Malaysia, China, and internationally with a market cap of SGD336.71 million. Operations: The company generates revenue primarily from its Core Dental Business, which accounts for SGD173.79 million, alongside Other Businesses contributing SGD6.89 million. Market Cap: SGD336.71M Q & M Dental Group (Singapore) Limited, with a market cap of SGD336.71 million, is trading at a significant discount to its estimated fair value. Despite experiencing a large one-off loss of SGD5.2 million in 2024, the company has demonstrated strong earnings growth of 27.1% over the past year, outpacing the healthcare industry average. The management team is experienced with satisfactory debt levels and well-covered interest payments by EBIT (4.4x coverage). Recent share buyback authorization reflects strategic capital management while maintaining stable weekly volatility and improved profit margins year-on-year from 6.3% to 8.1%. Unlock comprehensive insights into our analysis of Q & M Dental Group (Singapore) stock in this financial health report. Review our growth performance report to gain insights into Q & M Dental Group (Singapore)'s future. Embark on your investment journey to our 1,169 Asian Penny Stocks selection here. Seeking Other Investments? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:6616 SGX:AWI and SGX:QC7. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data
Yahoo
26-05-2025
- Business
- Yahoo
3 Asian Penny Stocks With Market Caps Over US$300M
Amidst a backdrop of global economic uncertainties, Asian markets have shown resilience, with investors keenly observing developments in trade policies and economic indicators. Penny stocks, though an older term, continue to captivate attention as they represent smaller or newer companies that may offer unique value propositions. This article will explore three Asian penny stocks that stand out for their financial strength and potential growth opportunities, appealing to those looking for promising investments beyond the mainstream. Name Share Price Market Cap Financial Health Rating North East Rubber (SET:NER) THB4.20 THB7.76B ★★★★☆☆ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.06 SGD8.11B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.87 HK$3.23B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.47 HK$51.18B ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$719.28M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.21 HK$2.02B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.15 HK$1.79B ★★★★★★ Click here to see the full list of 1,177 stocks from our Asian Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: NZX Limited operates a stock exchange in New Zealand and has a market capitalization of approximately NZ$525.66 million. Operations: The company's revenue segments include Regulation (NZ$4.00 million), Wealth Tech. (NZ$9.73 million), Funds Services (NZ$44.01 million), Secondary Markets (NZ$25.99 million), Corporate Services (NZ$0.10 million), Information Services (NZ$19.91 million), and Capital Markets Origination (NZ$17.02 million). Market Cap: NZ$525.66M NZX Limited, with a market capitalization of approximately NZ$525.66 million, demonstrates financial stability and growth potential in the penny stock realm. Its diversified revenue streams include significant contributions from Funds Services (NZ$44.01 million) and Secondary Markets (NZ$25.99 million). The company has effectively reduced its debt to equity ratio from 60.8% to 48.4% over five years, with interest payments well covered by EBIT at 8.5 times coverage. Despite a large one-off gain impacting recent results, earnings have grown by 88.1% in the past year, outpacing industry averages and showcasing robust profit margins of 21.1%. Take a closer look at NZX's potential here in our financial health report. Assess NZX's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Perfect Medical Health Management Limited is an investment holding company that provides medical, aesthetic medical, and beauty and wellness services across Hong Kong, the People's Republic of China, Macau, Australia, and Singapore with a market cap of HK$2.96 billion. Operations: The company generates HK$1.30 billion in revenue from its services in medical, aesthetic medical, and beauty and wellness sectors. Market Cap: HK$2.96B Perfect Medical Health Management, with a market cap of HK$2.96 billion, operates in the medical and wellness sectors across several regions. Despite trading at 71.2% below its estimated fair value, the company shows financial resilience with short-term assets exceeding both long- and short-term liabilities. Its management and board are seasoned, averaging over 13 years of experience each. Although earnings have declined by 2.7% annually over five years and recent profit growth is negative, its return on equity remains outstanding at 62.3%. However, the high dividend yield of 12.12% is not well supported by earnings or cash flow. Unlock comprehensive insights into our analysis of Perfect Medical Health Management stock in this financial health report. Learn about Perfect Medical Health Management's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: New Focus Auto Tech Holdings Limited is an investment holding company involved in the manufacturing and sales of electronic and power-related automotive parts and accessories across China, the Americas, Europe, and the Asia Pacific, with a market cap of HK$895.28 million. Operations: The company's revenue is primarily derived from two segments: CN¥382.78 million from the Manufacturing and Trading Business and CN¥135.73 million from the Automobile Dealership and Service Business. Market Cap: HK$895.28M New Focus Auto Tech Holdings, with a market cap of HK$895.28 million, faces challenges as its auditor expressed doubts about its ability to continue as a going concern. The company reported CN¥518.52 million in sales for 2024, down from the previous year, with a net loss of CN¥67.92 million. Despite reducing losses over five years and having satisfactory debt levels, short-term assets do not cover liabilities. While it maintains sufficient cash runway for over three years if free cash flow remains stable, the board's lack of experience and ongoing unprofitability present significant risks for investors in penny stocks. Click here and access our complete financial health analysis report to understand the dynamics of New Focus Auto Tech Holdings. Learn about New Focus Auto Tech Holdings' historical performance here. Dive into all 1,177 of the Asian Penny Stocks we have identified here. Seeking Other Investments? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NZSE:NZX SEHK:1830 and SEHK:360. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
26-05-2025
- Business
- Yahoo
3 Asian Penny Stocks With Market Caps Over US$300M
Amidst a backdrop of global economic uncertainties, Asian markets have shown resilience, with investors keenly observing developments in trade policies and economic indicators. Penny stocks, though an older term, continue to captivate attention as they represent smaller or newer companies that may offer unique value propositions. This article will explore three Asian penny stocks that stand out for their financial strength and potential growth opportunities, appealing to those looking for promising investments beyond the mainstream. Name Share Price Market Cap Financial Health Rating North East Rubber (SET:NER) THB4.20 THB7.76B ★★★★☆☆ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.06 SGD8.11B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.87 HK$3.23B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.47 HK$51.18B ★★★★★★ Lever Style (SEHK:1346) HK$1.14 HK$719.28M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.21 HK$2.02B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.15 HK$1.79B ★★★★★★ Click here to see the full list of 1,177 stocks from our Asian Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: NZX Limited operates a stock exchange in New Zealand and has a market capitalization of approximately NZ$525.66 million. Operations: The company's revenue segments include Regulation (NZ$4.00 million), Wealth Tech. (NZ$9.73 million), Funds Services (NZ$44.01 million), Secondary Markets (NZ$25.99 million), Corporate Services (NZ$0.10 million), Information Services (NZ$19.91 million), and Capital Markets Origination (NZ$17.02 million). Market Cap: NZ$525.66M NZX Limited, with a market capitalization of approximately NZ$525.66 million, demonstrates financial stability and growth potential in the penny stock realm. Its diversified revenue streams include significant contributions from Funds Services (NZ$44.01 million) and Secondary Markets (NZ$25.99 million). The company has effectively reduced its debt to equity ratio from 60.8% to 48.4% over five years, with interest payments well covered by EBIT at 8.5 times coverage. Despite a large one-off gain impacting recent results, earnings have grown by 88.1% in the past year, outpacing industry averages and showcasing robust profit margins of 21.1%. Take a closer look at NZX's potential here in our financial health report. Assess NZX's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Perfect Medical Health Management Limited is an investment holding company that provides medical, aesthetic medical, and beauty and wellness services across Hong Kong, the People's Republic of China, Macau, Australia, and Singapore with a market cap of HK$2.96 billion. Operations: The company generates HK$1.30 billion in revenue from its services in medical, aesthetic medical, and beauty and wellness sectors. Market Cap: HK$2.96B Perfect Medical Health Management, with a market cap of HK$2.96 billion, operates in the medical and wellness sectors across several regions. Despite trading at 71.2% below its estimated fair value, the company shows financial resilience with short-term assets exceeding both long- and short-term liabilities. Its management and board are seasoned, averaging over 13 years of experience each. Although earnings have declined by 2.7% annually over five years and recent profit growth is negative, its return on equity remains outstanding at 62.3%. However, the high dividend yield of 12.12% is not well supported by earnings or cash flow. Unlock comprehensive insights into our analysis of Perfect Medical Health Management stock in this financial health report. Learn about Perfect Medical Health Management's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: New Focus Auto Tech Holdings Limited is an investment holding company involved in the manufacturing and sales of electronic and power-related automotive parts and accessories across China, the Americas, Europe, and the Asia Pacific, with a market cap of HK$895.28 million. Operations: The company's revenue is primarily derived from two segments: CN¥382.78 million from the Manufacturing and Trading Business and CN¥135.73 million from the Automobile Dealership and Service Business. Market Cap: HK$895.28M New Focus Auto Tech Holdings, with a market cap of HK$895.28 million, faces challenges as its auditor expressed doubts about its ability to continue as a going concern. The company reported CN¥518.52 million in sales for 2024, down from the previous year, with a net loss of CN¥67.92 million. Despite reducing losses over five years and having satisfactory debt levels, short-term assets do not cover liabilities. While it maintains sufficient cash runway for over three years if free cash flow remains stable, the board's lack of experience and ongoing unprofitability present significant risks for investors in penny stocks. Click here and access our complete financial health analysis report to understand the dynamics of New Focus Auto Tech Holdings. Learn about New Focus Auto Tech Holdings' historical performance here. Dive into all 1,177 of the Asian Penny Stocks we have identified here. Seeking Other Investments? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NZSE:NZX SEHK:1830 and SEHK:360. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
